145
Views
0
CrossRef citations to date
0
Altmetric
Methods in Addiction Research

Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial

, , , , , , , , , , & show all
Pages 162-172 | Received 06 Jul 2023, Accepted 11 Nov 2023, Published online: 29 Jan 2024

References

  • Witkiewitz K, Tucker JA. Abstinence not required: expanding the definition of recovery from alcohol use disorder. Alcohol Clin Exp Res. 2020;44:36–40. doi:10.1111/acer.14235.
  • Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. 2020;156.
  • Alessi SM, Petry NM. A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Addiction. 2013;108:900–09. doi:10.1111/add.12093.
  • Barnett NP, Tidey J, Murphy JG, Swift R, Colby SM. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug Alcohol Depend. 2011;118:391–99. doi:10.1016/j.drugalcdep.2011.04.023.
  • Hammond AS, Sweeney MM, Chikosi TU, Stitzer ML. Digital delivery of a contingency management intervention for substance use disorder: a feasibility study with DynamiCare Health. J Subst Abuse Treat. 2021;126:108425. doi:10.1016/j.jsat.2021.108425.
  • Oluwoye O, Reneau H, Herron J, Alcover KC, McPherson S, Roll J, McDonell MG. Pilot study of an integrated smartphone and breathalyzer contingency management intervention for alcohol use. J Addict Med. 2020;14:193–98. doi:10.1097/ADM.0000000000000553.
  • Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, Festinger DS. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109:1426–36. doi:10.1111/add.12589.
  • Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192–203. doi:10.1111/j.1360-0443.2006.01311.x.
  • McDonell MG, Hirchak KA, Herron J, Lyons AJ, Alcover KC, Shaw J, Kordas G, Dirks LG, Jansen K, Avey J, et al. Effect of incentives for alcohol abstinence in partnership with 3 American Indian and Alaska Native communities: a randomized clinical trial. JAMA Psychiarty. 2021;78:599–606.
  • McDonell MG, Leickly E, McPherson SM, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK. A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. Am J Psychiatry. 2017;174:370–77. doi:10.1176/appi.ajp.2016.16050627.
  • McDonell MG, Skalisky J, Burduli E, Foote A, Granbois A, Smoker K, Hirchak K, Herron J, Ries RK, Echo‐Hawk A, et al. The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community. Addiction. 2021;116:1569–79. doi:10.1111/add.15349.
  • Villalba K, Cook C, Dévieux JG, Ibanez GE, Oghogho E, Neira C, Cook RL. Facilitators and barriers to a contingency management alcohol intervention involving a transdermal alcohol sensor. Heliyon. 2020;6:e03612. doi:10.1016/j.heliyon.2020.e03612.
  • Javors MA, Hill-Kapturczak N, Roache JD, Karns‐Wright TE, Dougherty DM. Characterization of the pharmacokinetics of phosphatidylethanol 16: 0/18: 1 and 16: 0/18: 2 in human whole blood after alcohol consumption in a clinical laboratory study. Alcohol Clin Exp Res. 2016;40:1228–34. doi:10.1111/acer.13062.
  • Hill-Kapturczak N, Dougherty DM, Roache JD, Karns‐Wright TE, Javors MA. Differences in the synthesis and elimination of phosphatidylethanol 16: 0/18: 1 and 16: 0/18: 2 after acute doses of alcohol. Alcohol Clin Exp Res. 2018;42:851–60. doi:10.1111/acer.13620.
  • McDonell MG, Skalisky J, Leickly E, Orr MF, McPherson S, Roll J, Hill-Kapturczak N, Javors M. Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use. Psychol Addict Behav. 2017;31:608–13. doi:10.1037/adb0000293.
  • Fraser ER, Hill-Kapturczak N, Jett J, Beck R, Oluwoye O, Kriegel LS, Alcover KC, McPherson S, Cabassa LJ, Javors M, et al. Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disorders. Contem Clin Trials Commun. 2021;22:100757.
  • Leickly E, Skalisky J, Oluwoye O, McPherson SM, Srebnik D, Roll JM, Ries RK, McDonell MG. Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness. Subst Abus. 2017;39:271–274. doi:10.1080/08897077.2017.1391926.
  • Ulwelling W, Smith K. The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines. J Forensic Sci. 2018;63:1634–40. doi:10.1111/1556-4029.13874.
  • Luginbühl M, Wurst FM, Stöth F, Weinmann W, Stove CP, Van Uytfanghe K. Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). Drug Test Anal. 2022;14:1800–02. doi:10.1002/dta.3340.
  • Ginley MK, Pfund RA, Rash CJ, Zajac K. Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: a meta-analysis. J Consult Clin Psychol. 2021;89:58–71. doi:10.1037/ccp0000552.
  • Appelbaum PS, Grisso T. MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota (FL): Professional Resource Press; 2001.
  • Wong A, Nyenhuis D, Black SE, Law LS, Lo ES, Kwan PW, Au L, Chan AY, Wong LK, Nasreddine Z, et al. The MoCA 5-min protocol is a brief, valid, reliable and feasible cognitive screen for telephone administration. Stroke. 2015;46:1059–64. doi:10.1161/STROKEAHA.114.007253.
  • Oluwoye O, Skalisky J, Burduli E, Chaytor NS, McPherson S, Murphy SM, Herron J, Hirchak K, Burley M, Ries RK, et al. Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness. Contemp Clin Trials. 2018;69:92–98.
  • Jett JD, Beck R, Tyutyunnyk D, Sanchez J, Lopez‐Cruzan M, Ginsburg BC, McPherson SM, Javors MA, McDonell MG, Hill‐Kapturczak N, et al. Validation of the quantification of phosphatidylethanol 16: 0/18: 1 concentrations in TASSO-M20 devices. Alcohol Clin Exp Res. 2023;47:748–55.
  • Attkisson C, Greenfield T. The Client Satisfaction Questionnaire (CSQ) Scales | Request PDF [Internet]. ResearchGate. [accessed 2018 Oct 26]. https://www.researchgate.net/publication/265377848_The_Client_Satisfaction_Questionnaire_CSQ_Scales.
  • North CS, Eyrich KM, Pollio DE, Foster DA, Cottler LB, Spitznagel EL. The homeless supplement to the diagnostic interview schedule: test-retest analyses. Int J Method Psychiat Res. 2004;13:184–91. doi:10.1002/mpr.174.
  • Tsemberis S, McHugo G, Williams V, Hanrahan P, Stefancic A. Measuring homelessness and residential stability: the residential time-line follow-back inventory. J Community Psychol. 2007;35:29–42. doi:10.1002/jcop.20132.
  • Pfund RA, Ginley MK, Rash CJ, Zajac K. Contingency management for treatment attendance: a meta-analysis. J Subst Abuse Treat. 2022;133:108556.
  • Bolívar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis. JAMA Psychiarty. 2021;78:1092–102. doi:10.1001/jamapsychiatry.2021.1969.
  • Hill-Kapturczak N, Javors MA, Moon TJ, Roache JD, Lopez-Cruzan M, Ginsburg BC, Wood, EE, Dougherty, DM. Evaluating levels of alcohol consumption among DWI arrestees one month after a contingency management intervention using phosphatidyleth anol levels. Alcohol Clin Exp Res. 2022;46:206A. Abstract No. 003, 309A.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.